Results 281 to 290 of about 2,642,809 (351)

Osteosarcopenia in Chronic Kidney Disease: An Overlooked Syndrome?

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 2, April 2025.
ABSTRACT Background Healthy ageing relies on maintaining physiological systems, particularly the musculoskeletal system (MKS). After 50, declines in bone density, muscle mass and strength increase the risk of osteoporosis and sarcopenia, leading to frailty, fractures and higher healthcare costs.
Lara Caldiroli   +6 more
wiley   +1 more source

Characteristics of Superficial Gastric Neoplasms Detected Not by White Light Imaging but by Linked Color Imaging

open access: yesJGH Open, Volume 9, Issue 4, April 2025.
ABSTRACT Background and Aims Laser endoscopy has a linked color imaging (LCI) mode which has been reported to be superior to white light imaging (WLI) in detecting early gastric cancer (EGC). In this study, we retrospectively investigated the characteristics of superficial gastric neoplasms detected not by WLI but by LCI.
Minoru Yamaoka   +8 more
wiley   +1 more source

Unmasking an Incidental Trichuris trichiura Infection in a Patient With Acute Hepatobiliary and Gastrointestinal Illness

open access: yesJGH Open, Volume 9, Issue 4, April 2025.
ABSTRACT Background Trichuris trichiura is a common intestinal parasite, but its systemic impact remains unclear. While severe infections may cause gastrointestinal complications, hepatobiliary involvement is rare. This case describes an incidental T.
Yung‐Che Chou   +2 more
wiley   +1 more source

INTRAGASTRIC CARBON MONOXIDE IN PATIENTS WITH CHRONIC GASTRITIS

open access: bronze, 2003
Yoshihisa Urita   +6 more
openalex   +1 more source

Real World Management of Cytopenias and Infections in Patients With Myelofibrosis Treated With Ruxolitinib

open access: yeseJHaem, Volume 6, Issue 2, April 2025.
ABSTRACT Introduction Ruxolitinib was the first JAK2 inhibitor approved for the treatment of primary and secondary myelofibrosis. It is currently used worldwide as first‐line therapy for advanced disease (intermediate‐2 and high‐risk) and is effective in polycythaemia vera (PV) and essential thrombocythaemia (ET), but not funded for this indication in ...
Liesl A. Butler   +3 more
wiley   +1 more source

Beyond Childhood: Adult and Adolescent Sickle Cell Disease and Outcomes in Northern Ghana

open access: yeseJHaem, Volume 6, Issue 2, April 2025.
ABSTRACT Background Adults and adolescents face different barriers to healthcare utilization compared to children. Objective To describe adult and adolescent sickle cell disease (SCD) and outcomes in northern Ghana. Methods This was a retrospective cohort study of SCD patients aged 13 years and above, admitted between January 1, 2021 and December 31 ...
Kwadwo Faka Gyan   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy